Secondary Bone Defect in Neuromuscular Diseases in Childhood: A Longitudinal “Muscle-Bone Unit” Analysis

Abstract

To evaluate the potential bone defect in neuromuscular diseases, we conducted a longitudinal study including three groups of patients: 14 Duchenne muscular dystrophies (DMD) and 2 limb-girdle muscular dystrophies (LGMD); 3 Becker muscular dystrophies (BeMD) and 7 spinal muscular atrophies (SMA). Yearly osteodensitometries assessed body composition and bone mineral density (BMD) associated with bone markers and leptin. Along the 7-year study, 107 osteodensitometries showed that bone status evolved to osteopenia in most patients except BeMD. When analyzing the crude values, BMD improved with age in BeMD and SMA but not in DMD/LGMD. The correlation using the Z-scores displayed a decrease in BMD with age in DMD/LGMD for all regions, in SMA at total body less head, whereas BMD increased in BeMD at lumbar spine. As observed in healthy persons, muscular mass and bone tissue were significantly correlated. Glucocorticoids were deleterious on trabecular and cortical bone. Leptin was high in most patients and correlated to fat mass and bone parameters. This study confirms a secondary bone defect in neuromuscular diseases, further confirming the functional relationship between bone and muscle and arguing for regular bone follow-up in patients to prevent fracture risk. Adipose tissue seems to interfere with bone remodeling in neuromuscular diseases.

Keywords

functional muscle-bone unit - neuromuscular diseases - bone mineral density - osteopenia - glucocorticoid - leptin

Financial Support

None.

• References

• 1 Frost HM. Bone's mechanostat: a 2003 update. Anat Rec A Discov Mol Cell Evol Biol 2003; 275 (02) 1081-1101
• 2 Schoenau E, Neu CM, Beck B, Manz F, Rauch F. Bone mineral content per muscle cross-sectional area as an index of the functional muscle-bone unit. J Bone Miner Res 2002; 17 (06) 1095-1101
• 3 Veilleux LN, Rauch F. Muscle-bone interactions in pediatric bone diseases. Curr Osteoporos Rep 2017; 15 (05) 425-432
• 4 Wong BL, Rybalsky I, Shellenbarger KC. , et al. Long-term outcome of interdisciplinary management of patients with Duchenne muscular dystrophy receiving daily glucocorticoid treatment. J Pediatr 2017; 182: 296-303.e1
• 5 Wasserman HM, Hornung LN, Stenger PJ. , et al. Low bone mineral density and fractures are highly prevalent in pediatric patients with spinal muscular atrophy regardless of disease severity. Neuromuscul Disord 2017; 27 (04) 331-337
• 6 Gordon CM, Leonard MB, Zemel BS. ; International Society for Clinical Densitometry. 2013 Pediatric Position Development Conference: executive summary and reflections. J Clin Densitom 2014; 17 (02) 219-224
• 7 Rauch F, Plotkin H, DiMeglio L. , et al. Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2007 Pediatric Official Positions. J Clin Densitom 2008; 11 (01) 22-28
• 8 Anitha D, Lee T. Assessing bone quality in terms of bone mineral density, buckling ratio and critical fracture load. J Bone Metab 2014; 21 (04) 243-247
• 9 Boutroy S, Hans D, Sornay-Rendu E, Vilayphiou N, Winzenrieth R, Chapurlat R. Trabecular bone score improves fracture risk prediction in non-osteoporotic women: the OFELY study. Osteoporos Int 2013; 24 (01) 77-85
• 10 Ricotti V, Ridout DA, Scott E. , et al; NorthStar Clinical Network. Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatry 2013; 84 (06) 698-705
• 11 Reid IR. Fat and bone. Arch Biochem Biophys 2010; 503 (01) 20-27